GET DAILY SIGNALSWhy Is Novanta (NOVT) Stock Down -15.70% Today?
Key Takeaways
- NOVT shares tumbled roughly 15.70% to about $123.06, down from a prior close of $145.98.
- The primary catalyst was a cautious fourth-quarter and full-year guidance reset that overshadowed a headline earnings beat.
- A secondary driver was a steep decline in GAAP profitability tied to costs from the Riverpoint Medical acquisition.
- The sell-off reflects profit-taking after a strong run, with the stock up roughly 40% over the prior 12 months.
- Traders are now watching Riverpoint integration progress, bookings momentum, and whether the pullback stabilizes.
- For more detail, explore Novanta's Price Targets, Earnings, and Forecast pages.
- Discover how automated strategies are positioning for moves like this on Trending AI Robots.
Opening Summary
Novanta Inc. (NOVT), a provider of precision photonics, vision, and motion-control technologies used by medical and advanced-industrial equipment makers, fell sharply in Monday's trading. Shares dropped 15.70% to $123.06, down from a prior close of $145.98, as investors reacted to the company's third-quarter earnings report and forward guidance. While the headline numbers topped Wall Street expectations, a below-consensus outlook for the current quarter and a reduced full-year profit view triggered an aggressive sell-off.
Earnings Beat Overshadowed by Guidance
The company reported third-quarter adjusted earnings of $1.05 per share on revenue of $305 million, up 23% year over year and ahead of analyst expectations. Organic revenue growth approached 10%, its strongest in more than three years, while adjusted EBITDA rose 38% to $80 million. Customer bookings increased 29%, pushing backlog to $543 million.
Despite these positives, the market focused on the outlook. Management guided fourth-quarter adjusted earnings to $0.91 to $0.96 per share, below the consensus estimate of roughly $1.02, and trimmed its full-year adjusted EPS view to a midpoint near $3.69. The conservative profit outlook, coming after a substantial run-up in the shares, gave investors a reason to lock in gains.
Riverpoint Acquisition Pressures GAAP Results
Another factor weighing on sentiment was the sharp decline in reported profitability. GAAP net income fell to about $2.0 million, or $0.05 per share, compared with $10.7 million, or $0.30 per share, a year earlier. Operating margin narrowed to 4.6% from 11.5%. The compression reflects deal-related charges and added interest expense from the company's largest-ever acquisition, Riverpoint Medical, a roughly $1.45 billion transaction completed in July. While management framed the integration as on track, the gap between adjusted and GAAP results drew investor scrutiny.
Market Context and Trading Activity
Trading volume was elevated relative to recent sessions as investors repositioned following the report. The decline was stock-specific, driven by guidance rather than broad market weakness, and shares sliced through several short-term technical levels during the session. The move reflects a classic post-earnings pattern in which a strong share-price run leaves little room for error on forward estimates, even when current-quarter results beat.
What Comes Next for NOVT
Looking ahead, investors will monitor progress on the Riverpoint Medical integration, the durability of the 29% bookings increase, and whether recurring consumables and medical revenue continue to expand as a share of the mix. The company's push toward a more medical, recurring, and less cyclical model remains intact, but the fourth-quarter earnings outlook will be a key test. Risks include integration execution, deal-related costs, and any softening in robotics, life sciences, or semiconductor end markets.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that are currently performing well. Tickeron offers hundreds of automated trading bots covering thousands of tickers, but only the strongest performers under prevailing market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a way to monitor systematic approaches to names like NOVT. Explore the page to see which strategies are leading right now.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NOVT in upward trend: price may jump up because it broke its lower Bollinger Band on November 10, 2026
NOVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 43 cases where NOVT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 64 cases where NOVT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The 10-day moving average for NOVT crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.
Following a +10.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOVT advanced for three days, in 195 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NOVT as a result. In 74 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for NOVT turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 36 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
NOVT moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for NOVT moved below the 200-day moving average on November 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. NOVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.162) is normal, around the industry mean (1.448). P/E Ratio (85.000) is within average values for comparable stocks, (5.350). NOVT's Projected Growth (PEG Ratio) (23.270) is slightly higher than the industry average of (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (5.043) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of manufactures and sells precision photonic and motion control components
Industry ElectronicEquipmentInstruments
Advertisement